The Economist

00:00

Oct 12, 2016 Our technology editor examines the long-term fallout after Samsung's flagship smartphone is pulled from production. The Food and Drug Administration's approval of a new drug for muscular dystrophy proves controversial and Matt Kaplan explains why higher-class people spend less time looking at their fellow humans

You're listening to
The Economist
on demand via

Personalized news and talk radio for your commute, workout and on-the-go.